Safety Alerts & Recalls

Marcaine Recalled Due to Visible Particulates

Hospira announced a voluntary nationwide recall of one lot of 0.25% Marcaine (bupivacaine HCl) injection, single-dose 10mL vials due to discolored solution with visible particles embedded in the glass as well as the presence of discolored solution.

Particulate Found in Lidocaine HCl Inj

Hospira has initiated a voluntary recall of one lot of Lidocaine HCl injection 1%, 10mg/mL, single-dose 30mL vials due to an orange and black particulate found within the solution and embedded within the glass vial.

Particulate Matter Found in Cubicin Vial

Cubist Pharmaceuticals announced a voluntary recall of one lot of Cubicin (daptomycin for injection) 500mg in 10mL vials, following a consumer complaint of particulate matter.

Voluntary Recall Issued for Appetite Suppressant

Nature's Universe announced a voluntary recall of all lots of old Thinogenics product due to the presence of an undisclosed ingredient, to the user level.

RECALL: Propofol Injectable Metal Particles Found

The FDA announced a nationwide recall of seven lots of Propofol Injectable Emulsion 1% (Hospira), due to visible metal particles embedded in the glass to the user level.

FDA Discourages Laparoscopic Power Morcellation in Hysterectomy, Myomectomy

The FDA is discouraging the use of laparoscopic power morcellation for the removal of the uterus or uterine fibroids in women based on a recent analysis of currently available data.

Hidden Ingredient Discovered in Sexual Enhancement Supplement

The FDA has warned consumers that the sexual enhancement supplement S.W.A.G. contains an undisclosed ingredient and should not be purchased or used.

Dangerous Ingredient Found in Weight Loss Products

The FDA is advising consumers to not buy or use Infinity capsules or Lite Fit USA softgels, products that are marketed and sold for weight loss.

Undeclared Drugs Found in New You Product

The FDA is warning consumers to avoid using or purchasing the herbal weight loss product New You after a laboratory analysis discovered undeclared sibutramine and phenolphthalein.

FDA Clarifies Its Position on Revatio Use in Children

The FDA announced clarifications to its previous recommendation related to prescribing Revatio (sildenafil; Pfizer) for children with pulmonary arterial hypertension (PAH).